A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials
Conclusions
Dedicated methods can be used to analyze toxicities from all cycles of treatment. They do not delay accrual and should be integrated in the analysis and reporting of phase I dose-finding trials.
Source: Annals of Oncology - Category: Cancer & Oncology Authors: Doussau, A., Thiebaut, R., Geoerger, B., Schoffski, P., Floquet, A., Le Deley, M. C., Mathoulin-Pelissier, S., Rizzo, E., Fumoleau, P., Le Tourneau, C., Paoletti, X. Tags: clinical trials Source Type: research
More News: Brain Stem Giloma | Brain Tumor | Cancer & Oncology | Carcinoma | Clinical Trials | Glioma | Ovarian Cancer | Ovaries | Tarceva | Toxicology